SCHEMBL7094166

SCHEMBL7094166

Brc1cc(Br)c(OCCCN2CCN(c3cccc4[nH]ccc34)CC2)c(Br)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.54
DRD3 P35462 3/20 0.54
DRD4 P21917 1/20 0.54
GAA P10253 5/20 0.51
MAPT P10636 3/20 0.50
ADRA1A P35348 1/20 0.48
ADRB1 P08588 1/20 0.46
HTR6 P50406 1/20 0.46
MEN1 O00255 1/20 0.45
GFER P55789 1/20 0.45
KMT2A Q03164 1/20 0.45
GOT1 P17174 2/20 0.44
FAAH O00519 1/20 0.44
CNR1 P21554 1/20 0.44
HTR2A P28223 3/20 0.43
HTR7 P34969 2/20 0.43
HTR1A P08908 1/20 0.42
KCNH2 Q12809 1/20 0.42
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7093864 0.90 DRD2 (0.51) DRD2DRD3DRD4GAAMAPT
SCHEMBL7090647 0.89 DRD2 (0.49) DRD2DRD3DRD4GAAMAPT
SCHEMBL7092045 0.89 DRD2 (0.55) DRD2DRD3DRD4GAAMAPT
SCHEMBL7096673 0.87 DRD2 (0.49) DRD2DRD3DRD4GAAMAPT
SCHEMBL7094177 0.87 DRD2 (0.55) DRD2DRD3DRD4GAAMAPT
SCHEMBL7093565 0.84 DRD3 (0.55) DRD2DRD3DRD4GAAMAPT
SCHEMBL7090560 0.83 GAA (0.53) DRD2DRD3DRD4GAAMAPT
SCHEMBL7094383 0.82 DRD2 (0.47) DRD2DRD3DRD4GAAMAPT
SCHEMBL29046800 0.81 DRD2 (0.66) DRD2DRD3DRD4GAAMAPT
SCHEMBL7093848 0.81 DRD2 (0.55) DRD2DRD3DRD4GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030050307-A1 Novel indole derivatives H. LUNDBECK A/S (DK) 2003-03-13 US claimed
US-20030050307-A1 Novel indole derivatives H. LUNDBECK A/S (DK) 2003-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030050307-A1 Novel indole derivatives HTR1A, HTR3C, HTR2C DRD2 27/4885DRD3 25/4885DRD4 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.